Metagenomic Next-Generation Sequencing for Pathogens in Bronchoalveolar Lavage Fluid Improves the Survival of Patients with Pulmonary Complications after Allogeneic Hematopoietic Stem Cell Transplantation.

Zaihong Shen,Ying Wang,Aihua Bao,Jun Yang,Xi Sun,Yu Cai,Liping Wan,Chongmei Huang,Xiaowei Xu,Jiahua Niu,Xinxin Xia,Chang Shen,Yu Wei,Huiying Qiu,Kun Zhou,Min Zhang,Yin Tong,Xianmin Song
DOI: https://doi.org/10.1007/s40121-023-00850-w
IF: 20.3
2022-01-01
Blood
Abstract:Unbiased metagenomic next-generation sequencing (mNGS) has been used for infection diagnosis. In this study, we explored the clinical diagnosis value of mNGS for pulmonary complications after allogeneic hematopoietic stem cell transplantation (allo-HSCT). From August 2019 to June 2021, a prospective study was performed to comparatively analyze the pathogenic results of mNGS and conventional tests for bronchoalveolar lavage fluid (BALF) from 134 cases involving 101 patients with pulmonary complications after allo-HSCT. More pathogens were identified by mNGS than with conventional tests (226 vs 120). For bacteria, the diagnostic sensitivity (P = 0.144) and specificity (P = 0.687) were similar between the two methods. For fungus except Pneumocystis jirovecii (PJ), conventional tests had a significantly higher sensitivity (P = 0.013) with a similarly high specificity (P = 0.109). The sensitivities for bacteria and fungi could be increased with the combination of the two methods. As for PJ, both the sensitivity (100
What problem does this paper attempt to address?